• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alchemia Ltd/Australia

+ Add to Watchlist

ACL:AU

0.6200 AUD 0.00000.00%

As of 02:10:55 ET on 07/14/2014.

Snapshot for Alchemia Ltd/Australia (ACL)

Open: 0.6250 Day's Range: 0.6200 - 0.6500 Volume: 1,763,416
Previous Close: 0.6200 52wk Range: 0.3100 - 0.6750 1-Yr Rtn: +90.77%

Stock Chart for ACL

No chart data available.
  • ACL:AU 0.6200
  • 1D
  • 1M
  • 1Y
0.6200
Interactive ACL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACL

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. AS51 -
Earnings Per Share (AUD) (ttm) -0.0131
Est. EPS (AUD) (06/2014) -0.0110
Est. PEG Ratio -
Market Cap (M AUD) 201.13
Shares Outstanding (M) 324.41
30 Day Average Volume 329,469
Price/Book (mrq) 7.2680
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACL

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for ACL

Alchemia Limited is a biotechnology company that develops carbohydrate based molecules for pharmaceutical applications. The Company's products are used in drug development in the field of antibiotics and anti-cancer drugs.

Thomas LiquardChief Executive OfficerWim MeutermansChief Scientific Ofcr:Audeo Discovery
Goslik SchepersVP:Business DevelopmentMichael L WestVP:Intellectual Property
More Company Profile & Key Executives for ACL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil